EFS
ELV icon

Essex Financial Services’s Elevance Health ELV Stock Holding History

Essex Financial Services’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$975K Sell
3,330
-151
-4% -$49.6K 0.05% 297
2025
Q4 		$1.22M Sell
3,481
-286
-8% -$96.6K 0.07% 237
2025
Q3 		$1.22M Sell
3,767
-1,328
-26% -$413K 0.07% 228
2025
Q2 		$1.98M Sell
5,095
-18
-0.4% -$7.24K 0.13% 155
2025
Q1 		$2.22M Buy
5,113
+41
+0.8% +$16.5K 0.16% 131
2024
Q4 		$1.87M Sell
5,072
-39
-0.8% -$16.3K 0.13% 143
2024
Q3 		$2.15M Sell
5,111
-232
-4% -$124K 0.15% 126
2024
Q2 		$2.81M Buy
5,343
+188
+4% +$99.4K 0.21% 101
2024
Q1 		$2.67M Sell
5,155
-126
-2% -$62.7K 0.25% 89
2023
Q4 		$2.49M Buy
5,281
+403
+8% +$186K 0.26% 86
2023
Q3 		$2.12M Buy
4,878
+160
+3% +$72.6K 0.25% 89
2023
Q2 		$2.1M Sell
4,718
-1,770
-27% -$817K 0.24% 90
2023
Q1 		$2.98M Sell
6,488
-925
-12% -$440K 0.31% 80
2022
Q4 		$3.8M Sell
7,413
-350
-5% -$178K 0.4% 59
2022
Q3 		$3.53M Buy
7,763
+975
+14% +$467K 0.42% 58
2022
Q2 		$3.28M Buy
6,788
+727
+12% +$360K 0.36% 68
2022
Q1 		$2.98M Sell
6,061
-1,047
-15% -$479K 0.29% 87
2021
Q4 		$3.29M Buy
7,108
+1,885
+36% +$793K 0.33% 72
2021
Q3 		$1.95M Buy
5,223
+2,380
+84% +$904K 0.22% 105
2021
Q2 		$1.02M Hold
2,843
– – 0.15% 148
2021
Q1 		$1.02M Sell
2,843
-88
-3% -$28.3K 0.18% 126
2020
Q4 		$941K Sell
2,931
-27
-0.9% -$8.29K 0.19% 120
2020
Q3 		$795K Buy
2,958
+102
+4% +$27.4K 0.2% 115
2020
Q2 		$751K Sell
2,856
-81
-3% -$21.6K 0.23% 108
2020
Q1 		$667K Buy
2,937
+185
+7% +$50.4K 0.24% 101
2019
Q4 		$831K Buy
2,752
+180
+7% +$49.5K 0.23% 99
2019
Q3 		$618K Sell
2,572
-163
-6% -$44.7K 0.2% 118
2019
Q2 		$772K Buy
2,735
+312
+13% +$85.2K 0.23% 95
2019
Q1 		$695K Sell
2,423
-5
-0.2% -$1.45K 0.21% 101
2018
Q4 		$638K Buy
2,428
+10
+0.4% +$2.75K 0.2% 107
2018
Q3 		$663K Hold
2,418
– – 0.15% 136
2018
Q2 		$576K Hold
2,418
– – 0.14% 143
2018
Q1 		$531K Hold
2,418
– – 0.1% 187
2017
Q4 		$544K Sell
2,418
-20
-0.8% -$4.26K 0.13% 143
2017
Q3 		$463K Buy
2,438
+665
+38% +$127K 0.11% 156
2017
Q2 		$334K Buy
1,773
+310
+21% +$55.7K 0.07% 248
2017
Q1 		$242K Sell
1,463
-3
-0.2% -$477 0.06% 284
2016
Q4 		$211K Buy
+1,466
New +$196K 0.05% 300
2015
Q3 		– Sell
-1,519
Closed -$249K – 326
2015
Q2 		$249K Buy
1,519
+191
+14% +$30.5K 0.06% 269
2015
Q1 		$205K Buy
+1,328
New +$189K 0.05% 301

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Essex Financial Services's ELV Position: Q1 2026 in Review

Essex Financial Services reduced its Elevance Health (ELV) stake by 4.3% in Q1 2026, selling an estimated $49.6K and leaving 3,330 shares worth $975K. The position accounts for 0.05% of the portfolio, ranked #297.

Essex Financial Services first reported a position in ELV in Q1 2015 and has held it in 40 quarters since. The position peaked at $3.8M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Essex Financial Services held 3,330 shares of Elevance Health worth $975K as of Q1 2026.
  • Essex Financial Services sold 151 Elevance Health shares in Q1 2026, an estimated $49.6K.
  • Elevance Health made up 0.05% of Essex Financial Services's portfolio in Q1 2026, its #297 holding.
  • Essex Financial Services first reported a position in Elevance Health in Q1 2015 and has held it in 40 quarters since.
  • Essex Financial Services's Elevance Health position peaked at $3.8M in Q4 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.